The extract acknowledges scholarly engagement with the ERS/EULAR clinical practice guidelines for connective tissue disease–associated interstitial lung disease (CTD-ILD). It notes interest from J.R.
Davidsen and colleagues concerning the guidelines recently published by ERS/EULAR. The authors express awareness of the rapidly evolving evidence base related to screening tools in rheumatoid arthritis–associated ILD (RA-ILD).
The quoted text does not provide data on specific recommendations, outcomes, or methodologies, and it explicitly limits its content to recognition of discourse and the ongoing evolution of screening evidence in RA-ILD. Any conclusions about the guidelines’ content, validation, or applicability would require referring to the full guideline publications themselves.
Given the brevity and extract nature, there is uncertainty regarding exact recommendations or changes in practice arising from these discussions. Clinicians should consult the complete ERS/EULAR CTD-ILD guidelines document for comprehensive guidance and for up-to-date screening approaches, noting that evidence in RA-ILD screening remains in flux according to the authors’ acknowledgment.
European Respiratory Journal published a clinical update in Critical Care on 02 Apr 2026.
The item focuses on Reply on behalf of the ERS/EULAR task force for connective tissue disease-associated interstitial lung disease.
Review the original article for the full source wording and details.